The standard move in this industry is the kitchen-sink stack: twelve compounds in a morning capsule, nine more at night, a list of brand names so long it stops meaning anything. The implicit promise is coverage — that if a little of everything is in the bottle, nothing important has been left out. We do the opposite, and the reason is not minimalism for its own sake.
Every well-studied longevity compound has a dose where the evidence begins and a dose where the evidence ends. Below the first, you are taking a rounding error. Above the second, you have left the data behind entirely and are running an experiment on yourself with no map. The useful window is narrower than the marketing suggests, and it is different for every molecule.
When you put twenty ingredients into a single formula, you cannot honor those windows. There is not enough room in a capsule, not enough room in a daily routine, and — crucially — not enough room in the evidence to know how twenty active compounds behave together. Interaction is not additive. Two things that each help in isolation can cancel, compete, or compound in ways no one has studied.
A short list is not a smaller version of a long list. It is a different claim about what is actually known.
So we made a harder choice. Three formulas, each built around compounds with human data, each dosed inside the window the evidence actually supports. Lixir for energy. Bio for the heart. Optima for skin, muscle, and bone. Nothing included because it tested well in a focus group; nothing included to lengthen the label.
This means saying no to ingredients customers ask for by name. It means a thinner story on the box and a quieter pitch. It also means that every line on our label is one we can defend — that there is a reason, and a citation, behind each gram.
Restraint, done properly, is not the absence of ambition. It is ambition pointed at the right target: not the longest possible list, but the most defensible one.
— ReHuman System
